HLB SCIENCE Inc. (XKON:343090)

Market Cap	26.51B
Revenue	n/a
Net Income	n/a
Shares Out	17.84M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,936
Average Volume	7,119
Open	1,450.00
Previous Close	1,538.00
Day's Range	1,450.00 - 1,535.00
52-Week Range	1,407.00 - 3,185.00
Beta	0.03
RSI	40.58
Earnings Date	n/a

About HLB SCIENCE

HLB SCIENCE Inc. develops biological drugs with MoA to infectious diseases. Its pipeline includes DD-S052P, a candidate that exterminates germs and eliminates endotoxins; DD-A279, a new treatment to cure Alzheimer's Diseases by controlling LPS and Gram-negative bacteria; and DD-A514, a diagnosis kit for Alzheimer's diseases. The company was formerly known as Dandi Bio Science Co.,Ltd. and changed its name to HLB SCIENCE Inc. in March 2023. The company was founded in 2016 and is based in Seoul, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2016
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 343090